Bronchopulmonary penetration of isavuconazole in lung transplant recipients

Isavuconazole’s (ISA) pharmacokinetics was studied among lung transplant recipients to evaluate its bronchopulmonary penetration. This study included 13 patients and showed mean serum concentrations of 3.30 (standard deviation [SD] 0.45), 5.12 (SD 1.36), and 6.31 (SD 0.95) at 2 h, 4 h, and 24 h resp...

Descripción completa

Detalles Bibliográficos
Autores: Caballero-Bermejo, Antonio F., Darnaude-Ximénez, Ignacio, Aguilar Pérez, Myriam, Gómez López, Alicia, Sancho-López, Aránzazu, López García-Gallo, Cristina, Díaz Nuevo, Gema, Diago-Sempere, Elena, Ruiz-Antorán, Belén, Ussetti Gil, Piedad, Avendaño Solá, Cristina
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Universidad Autónoma de Madrid
Repositorio:Biblos-e Archivo. Repositorio Institucional de la UAM
Idioma:inglés
OAI Identifier:oai:repositorio.uam.es:10486/719416
Acceso en línea:http://hdl.handle.net/10486/719416
https://dx.doi.org/10.1128/aac.00613-23
Access Level:acceso abierto
Palabra clave:bronchoalveolar lavage
invasive fungal infection
isavuconazole
lung transplant
tissue penetration
Medicina
Descripción
Sumario:Isavuconazole’s (ISA) pharmacokinetics was studied among lung transplant recipients to evaluate its bronchopulmonary penetration. This study included 13 patients and showed mean serum concentrations of 3.30 (standard deviation [SD] 0.45), 5.12 (SD 1.36), and 6.31 (SD 0.95) at 2 h, 4 h, and 24 h respectively. Mean concentrations in the epithelial lining fluid were 0.969 (SD 0.895), 2.141 (SD 1.265), and 2.812 (SD 0.693) at the same time points. ISA is a drug with a tolerable safety profile that achieves adequate concentrations in the lung

Similares en LA Referencia